Iv. Smirnova et al., CALCIUM MOBILIZATION AND PROTEASE-ACTIVATED RECEPTOR CLEAVAGE AFTER THROMBIN STIMULATION IN MOTOR-NEURONS, Journal of molecular neuroscience, 10(1), 1998, pp. 31-44
Thrombin, the ultimate enzyme in the blood coagulation cascade, has pr
ominent actions on various cells, including neurons. As in platelets,
thrombin increases [Ca2+](i) mobilization in neurons, and also retract
s neurites. Both these effects are mediated through a G protein-couple
d, proteolytically activated receptor for thrombin (PAR-1). Prolonged
exposure to thrombin kills neurons via apoptosis, that may also involv
e PAR-1 activation. Increased [Ca2+](i) has been a unifying mechanism
proposed for cell death in several neurodegenerative diseases. Thrombi
n-elevated calcium levels may activate intracellular cascades in neuro
ns leading to cell death. Since thrombin mediates its diverse effects
on cells through both heterotrimeric and monomeric G proteins, we also
explored what effect altering differential G protein coupling would h
ave on the neuronal response to thrombin. We studied calcium mobilizat
ion by thrombin in a model motor neuronal cell line, NSC19, using fluo
rescence image analysis. Confirming effects in other neuronal types, t
hrombin caused dramatic increases in [Ca2+](i) levels, both transientl
y and after prolonged exposure, which involved activation and cleavage
of the PAR-1 receptor. Using enzyme linked immunosorbent assay (ELISA
) and dot-blot analysis, we found that the N-terminal fragment of PAR-
1 was released into the medium after exposure to thrombin. We confirme
d that PAR-1 protein and mRNA expression occurred in motor neurons. We
found that cholera toxin inhibited thrombin-mediated Ca2+ influx, per
tussis toxin did not significantly alter thrombin action, and lovastat
in, a small 21-kDa Ras GTPase (Rho) modulator, showed a tendency to re
duce the thrombin effect. These data indicate that thrombin-increased
[Ca2+](i), sufficient to trigger cell death in motor neurons, might be
approached in vivo by modulating thrombin signaling through PAR-1.